The dietary flavonoid naringenin has been found to regulate the PKD2 protein responsible for polycystic kidney disease.
Found in grapefruits and other citrus fruits, naringenin inhibited the formation of cysts in vitro and in a mammalian kidney cell line.
When PKD2 levels were reduced in the cells, the block in cyst formation was also reduced. Mark A. Carew, PhD, of Kingston University, Kingston upon Thames, Surrey, U.K., and fellow researchers stated in the British Journal of Pharmacology that further studies will investigate naringenin as a potential new therapeutic agent in autosomal dominant polycystic kidney disease.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.